FLUPHENAZINE DECANOATE Drug Patent Profile
✉ Email this page to a colleague
When do Fluphenazine Decanoate patents expire, and what generic alternatives are available?
Fluphenazine Decanoate is a drug marketed by Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira, MSN, Mylan Labs Ltd, Par Sterile Products, and Teva Parenteral. and is included in nine NDAs.
The generic ingredient in FLUPHENAZINE DECANOATE is fluphenazine decanoate. There are nineteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the fluphenazine decanoate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fluphenazine Decanoate
A generic version of FLUPHENAZINE DECANOATE was approved as fluphenazine decanoate by FRESENIUS KABI USA on July 14th, 1987.
Summary for FLUPHENAZINE DECANOATE
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 9 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 57 |
| Clinical Trials: | 2 |
| Patent Applications: | 2,145 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for FLUPHENAZINE DECANOATE |
| DailyMed Link: | FLUPHENAZINE DECANOATE at DailyMed |
Recent Clinical Trials for FLUPHENAZINE DECANOATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tufts Medical Center | Phase 2 |
| Immune Control | Phase 2 |
| National Institute of Mental Health (NIMH) | Phase 4 |
Pharmacology for FLUPHENAZINE DECANOATE
| Drug Class | Phenothiazine |
Anatomical Therapeutic Chemical (ATC) Classes for FLUPHENAZINE DECANOATE
US Patents and Regulatory Information for FLUPHENAZINE DECANOATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma | FLUPHENAZINE DECANOATE | fluphenazine decanoate | INJECTABLE;INJECTION | 207739-001 | Oct 17, 2017 | AO | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Mylan Labs Ltd | FLUPHENAZINE DECANOATE | fluphenazine decanoate | INJECTABLE;INJECTION | 075918-001 | Aug 17, 2001 | AO | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Hikma | FLUPHENAZINE DECANOATE | fluphenazine decanoate | INJECTABLE;INJECTION | 074531-001 | Aug 30, 1996 | AO | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Par Sterile Products | FLUPHENAZINE DECANOATE | fluphenazine decanoate | INJECTABLE;INJECTION | 203732-001 | Jul 3, 2014 | AO | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Fresenius Kabi Usa | FLUPHENAZINE DECANOATE | fluphenazine decanoate | INJECTABLE;INJECTION | 071413-001 | Jul 14, 1987 | AO | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
